MedTrace Logo

Evaluation of the Quantra System in a Surgical Oncological Population

NCT04116385 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2020-09-01

No results posted yet for this study

Summary

This study will monitor coagulation parameters during the perioperative course of cancer surgical procedures using the Quantra System with the QPlus Cartridge.

Conditions

  • Blood Loss, Surgical

Interventions

DIAGNOSTIC_TEST

Quantra System

Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.

Sponsors & Collaborators

  • HemoSonics LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-15
Primary Completion
2020-03-12
Completion
2020-07-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04116385 on ClinicalTrials.gov